Publications
Yang JB, Shepherd BE, Lumley T, Shaw PA. Optimum Allocation for Adaptive Multi-Wave Sampling in R: The R Package optimall. Preprint arXiv:2106.09494. 2021 Jun 17. PDF
Lotspeich S, Shepherd BE, Amorim G, Shaw PA, Tao R. Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort. Biometrics 2021 July; Epub ahead of print.
Boe LA, Tinker LF, Shaw PA: An Approximate Quasi-Likelihood Approach for Error-Prone Failure Time Outcomes and Exposures. Statistics in Medicine (in press). Pre-Print
Amorim G, Tau R, Lotspeich SC, Shaw PA, Lumley T, Shepherd BE. Two-Phase Sampling Designs for Data Validation in Settings with Covariate Measurement Error and Continuous Outcome. Journal of the Royal Statistical Society, Series A (in press)
Oh E, Shepherd BE, Lumley T, Shaw PA: Improved Generalized Raking Estimators to Address Dependent Covariate and Failure-Time Outcome Error. Biometrical Journal. 2021 Jun; 63(5):1006-27. PDF
Baldoni P, Sotres-Alvarez D, Lumley TS, Shaw PA. On the use of Regression Calibration in a Complex Sampling Design with Application to the Hispanic Community Health Study/Study of Latinos. American Journal of Epidemiology, 2021 July; 190(7): 1366–1376. PDF
Oh EJ, Shepherd BE, Lumley T, Shaw PA. Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error. Statistics in Medicine. 2021;40(3):631–649. [PDF]
Tau R, Lotspeich SC, Shaw PA, Shepherd BE. Efficient semiparametric inference for two-phase studies with outcome and covariate measurement errors. Statistics in Medicine, 2021; 40(3):725–738.
Han K, Lumley T, Shepherd BE, Shaw PA: Two-phase analysis and study design for survival models with error-prone exposures. Statistical Methods in Medical Research, 2020 Dec 16. [PDF]
Shepherd BE, Shaw PA. Errors in multiple variables in HIV cohort and electronic health record data: statistical challenges and opportunities. Statistical Communications in Infectious Disease, 2020; 12 (s1), [PDF]
Shaw PA, He J, and Shepherd B. Regression calibration to correct correlated errors in outcome and exposure. Statistics in Medicine, 2021; 40(2): 271-286. [PDF]
Illenberger N, Small DS, and Shaw PA. Understanding regression to the mean in the context of synthetic controls and other matched difference in difference methods. Epidemiology 2020; 31(6):815-22. [PDF]
Giganti MJ, Shaw PA, Chen G, Bebawy SS, Turner MM, Sterling TR, Shepherd BE: Accounting for dependent errors in predictors and time-to-event outcomes using validation samples and multiple imputation Annals of Applied Statistics 2020;14(2):1045-61.
Keogh RH, Shaw PA, Gustafson P, Carroll RJ, Deffner V, Dodd KW, Küchenhoff H, Tooze JA, Wallace MP, Kipnis V, Freedman LS. STRATOS guidance document on measurement error and misclassification of variables in observational epidemiology: Part I – basic theory, validation studies and simple methods of adjustment. Statistics in Medicine 2020 Jul 20;39(16):2197-2231. [PDF]
Shaw PA, Gustafson P, Carroll RJ, Deffner V, Dodd KW, Keogh RH, Kipnis V, Tooze JA, Wallace MP, Küchenhoff H, Freedman LS. STRATOS guidance document on measurement error and misclassification of variables in observational epidemiology: Part II –more complex methods of adjustment and advanced topics. Statistics in Medicine 2020 Jul 20;39(16):2232-2263. [PDF]
Shaw PA, Deffner V, Dodd KW, Freedman LS, Keogh RH, Kipnis V, Kuechenhoff H, and Tooze JA for the Measurement Error and Misclassification Topic Group (TG4) of the STRATOS Initiative: Epidemiologic analyses with error-prone exposures: Review of current practice and recommendations. Annals of Epidemiology, 2018; 28(11): 821-828.
Freedman LS and Shaw PA.: On the formation and use of calibration equations in nutritional epidemiology- Discussion of the Paper by R. L. Prentice and Y. Huang. Statistical Theory and Related Fields, 2018; 2(1): 11-13.
Oh E, Shepherd B, Lumley T, Shaw PA. Considerations for analysis of time-to-event outcomes Measured with Error: Bias and correction with SIMEX. Statistics in Medicine, 2018 Apr; 37(8): 1276-1289. [PDF]
Wang L, Shaw PA, Mathelier HM, Kimmel SE, French B. Evaluating risk-prediction models using data from electronic health records. Annals of Applied Statistics, 2016 Mar;10(1):286-304. [PDF]
Shepherd B, Shaw PA and Dodd L. Using audit Information to adjust parameter estimates for data errors in clinical trials. Clinical Trials, 2012 Dec; 9(6): 721-729.
Shaw PA, Prentice, RL. Hazard ratio estimation for biomarker-calibrated dietary exposures. Biometrics, 2012 Jun; 68(2): 397-407. [PDF]
Lumley T, Shaw PA, Dai JY. Connections between survey calibration estimators and semiparametric models for incomplete data. International Statistical Review, 2011, 79 (2): 200–220. [PDF]
Shaw PA, Pepe MS, Alonzo TA, Etzioni R. Methods for assessing improvement in specificity when a biomarker is combined with a standard screening test. Statistics of Biopharmaceutical Research, 2009 Feb 1; 1 (1): 18-25.
Johnson JJ, Shaw PA, Oh EJ, Wooller MW, Merriman S, Yun HY, Larsen T, Krakoff J, Votruba SB, O’Brien DM. The carbon isotope ratios of nonessential amino acids identify sugar-sweetened beverage consumers in a 12-week clinical feeding study with varying SSB and meat exposures. To appear in American Journal of Clinical Nutrition. [PDF]
Hosgood DH, Slavkovich V, Hua S, Klugman M, Grau-Perez M, Graziano J, Shaw PA, Kaplan R, Navas-Acien A, Mossavar-Rahman Yi.: Urinary Arsenic Species are Detectable in Urban Underserved Hispanic Populations. International Journal of Environmental Research and Public Health. 2020 Mar 27;17(7):2247. doi: 10.3390/ijerph17072247. [PDF]
Votruba SB, Shaw PA, Oh EJ, Venti CA, Bonfiglio S, Bogardus C, Krakoff J, O’Brien DM. Associations of plasma, red blood cell and hair carbon and nitrogen isotope ratios with fish, meat and SSB intake in a 12-week inpatient feeding study. American Journal of Clinical Nutrition, 2019 Dec; 110(6): 1306-1315. [PDF]
Shaw PA, Deffner V, Dodd KW, Freedman LS, Keogh RH, Kipnis V, Kuechenhoff H, and Tooze JA for the Measurement Error and Misclassification Topic Group (TG4) of the STRATOS Initiative: Epidemiologic analyses with error-prone exposures: Review of current practice and recommendations. Annals of Epidemiology, 2018; 28(11): 821-828.
Jusko TA, van den Dries MA, Pronk A, Shaw PA, Guxens M, Spaan S, Jaddoe VW, Tiemeier H, and Longnecker MP: Organophosphate Pesticide Metabolite Concentrations in Urine during Pregnancy and Offspring Nonverbal IQ at Age 6 Years. Environmental Health Perspectives 127(1), Jan 2019; https://doi.org/10.1289/EHP3024.
Elfassy T, Mossavar-Rahmani Y, Van Horn L, Gellman M, Sotres-Alvarez D, Schneiderman N, Daviglus M, Beasley JM, Liabre MM, Shaw PA, Prado G, Florez H, Al Hazzouri, AZ: Associations of Sodium and Potassium with Obesity Measures Among Diverse US Hispanic/Latino Adults: Results from the Hispanic Community Health Study/Study of Latinos. Obesity. 26(2): 442-450, Feb 2018.
Mossavar-Rahmani Y, J, Wang R, Shaw PS, Jung M, Sotres-Alvarez D, Castañeda SF, Gallo LC, Gellman MD, Qi Q, Ramos MD AR, Reid KJ, Van Horn PhD L, Patel SR. Actigraphic sleep measures and diet quality in the Hispanic Community Health Study/Study of Latinos Sueño ancillary study. Journal of Sleep, 2017; 26(6): 739-746. [PDF]
Mossavar-Rahmani Y, Sotres-Alvarez D, Wong W, Loria C, Gellman M, Van Horn L, Alderman M, Beasley J, Lora C, Siega-Riz AM, Kaplan R, Shaw PA. Applying recovery biomarkers to calibrate self-report measures of sodium and potassium in the Hispanic Community Health Study/Study of Latinos Journal of Human Hypertension, 2017; 31(7): 462-473, Jul 2017. [PDF]
Beasley JM, Jung M, Tasevska N, Wong WW, Siega-Riz AM, Sotres-Alvarez D, Gellman MD, Kizer JR, Shaw PA, Stamler J; Stoutenberg M, Van Horn L, Wylie-Rosett J. Mossavar-Rahmani Y. Biomarker-predicted sugars intake compared with self-reported measures in US Hispanics/Latinos: Results from the HCHS/SOL SOLNAS Study. Public Health Nutrition, 2016 Dec;19(18):3256-3264. [PDF]
Mossavar-Rahmani Y, Shaw PA, Wong WW, Sotres-Alvarez D, Gellman MD, Van Horn L, Stoutenberg M, Daviglus ML, Wylie-Rosett J, Siega-Riz AM, Ou F, Prentice RL. Applying recovery biomarkers to calibrate self-report measures of energy and protein in the Hispanic Community Health Study/Study of Latinos. American Journal of Epidemiology, 2015; 181(12): 996-1007. [PDF]
Spaan S, Pronk A, Koch HM, Jusko TA, Jaddoe VW, Shaw PA, Tiemeier HM, Hofman A, Pierik FH, Longnecker MP. Reliability of concentrations of organophosphate pesticide metabolites in serial urine specimens from pregnancy in the Generation R study. Journal of Exposure Sciences and Environmental Epidemiology, 2015; 25(3): 286-294.
Prentice RL, Shaw PA, Bingham S A, Beresford SA, Caan B, Neuhouser ML, Patterson RE, Stefanick ML, Satterfield S, Thomson CA, Snetselaar L, Thomas A, Tinker LF. Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. American Journal of Epidemiology, 2009 Apr 15;169(8):977-89. [PDF]
Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Van Horn L, Beresford SA, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick ML, Assaf A, Runswick S and Prentice RL. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women’s Health Initiative. American Journal of Epidemiology, 2008 May 15; 167 (10): 1247-59. [PDF]
Oh E, Shepherd BE, Lumley T, Shaw PA: Improved Generalized Raking Estimators to Address Dependent Covariate and Failure-Time Outcome Error. To appear in Biometrical Journal. Pre-print, arXiv:2006.07480 [stat.ME].
Oh EJ, Shepherd BE, Lumley T, Shaw PA. Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error. Statistics in Medicine. 2021;40(3):631–649.
Han K, Lumley T, Shepherd BE, Shaw PA: Two-phase analysis and study design for survival models with error-prone exposures. Statistical Methods in Medical Research, 2020 Dec 16. EPub ahead of print: https://doi.org/10.1177/0962280220978500
Xu R, Mehrotra D, Shaw PA. Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample size. Pharmaceutical Statistics, 2019 May; 8(3):366-376. doi: 10.1002/pst.1928. doi: 10.1002/pst.1928. [PDF]
Xu R, Mehrotra D, Shaw PA. Incorporating baseline measurement into the analysis of crossover trials with time-to-event endpoints. Statistics in Medicine, 2018 Oct; 37 (23): 3280-3292. [PDF]
Oyama M, Shaw PA, and Ellenberg S.: Considerations for analysis of time-to-event outcomes subject to competing risks in veterinary clinical studies. Journal of Veterinary Cardiology, 20(3): 143-153, Jun 2018.
Oh E, Shepherd B, Lumley T, Shaw PA. Considerations for analysis of time-to-event outcomes Measured with Error: Bias and correction with SIMEX. Statistics in Medicine, 2018 Apr; 37(8): 1276-1289. [PDF]
Xu R, Shaw PA, Mehrotra DV: Hazard ratio estimation in small samples. Statistics in Biopharmaceutical Research 10(2): 139-149, 2018. [PDF]
Shaw PA, Fay MP: A rank test for bivariate event time outcomes when one event is a surrogate. Statistics in Medicine, 2016 Aug 30; 35(19):3413-23. [PDF]
Shaw PA, Prentice, RL. Hazard ratio estimation for biomarker-calibrated dietary exposures. Biometrics, 2012 Jun; 68(2): 397-407. [PDF]
Fay MP, Shaw PA. Exact and asymptotic weighted logrank tests for interval censored data: the interval R package. Journal of Statistical Software, 2010 Aug; 36 (2): 1-34. [PDF]
Proschan MA, Shaw PA. Diagnosing Fraudulent Baseline Data in Clinical Trials. PLoS ONE 2020;15(9):e0239121. [PDF]
Shaw PA. Use of composite outcomes to assess risk-benefit in clinical trials. Clinical Trials, 2018;15(4):352-8. [PDF]
Xu R, Mehrotra D, Shaw PA. Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample size. Pharmaceutical Statistics, 2019 May; 8(3):366-376. [PDF]
Xu R, Mehrotra D, Shaw PA. Incorporating baseline measurement into the analysis of crossover trials with time-to-event endpoints. Statistics in Medicine, 2018 Oct; 37 (23): 3280-3292. [PDF]
Xu R, Shaw PA, Mehrotra DV: Hazard ratio estimation in small samples. Statistics in Biopharmaceutical Research 10(2): 139-149, 2018.
Oyama M, Shaw PA, and Ellenberg S.: Considerations for analysis of time-to-event outcomes subject to competing risks in veterinary clinical studies. Journal of Veterinary Cardiology, 20(3): 143-153, Jun 2018. [PDF]
Oyama MA, Ellenberg SS, Shaw PA. Clinical trials in veterinary medicine: A new era brings new challenges. Journal of Veterinary Internal Medicine 2017 Jul;31(4):970-978. [PDF]
Shaw PA, Fay MP: A rank test for bivariate event time outcomes when one event is a surrogate. Statistics in Medicine, 2016 Aug 30; 35(19):3413-23.
Anderson GL, Burns CJ, Larsen J, Shaw PA. Use of administrative data to increase the practicality of clinical trials: Insights from the Women’s Health Initiative. Clinical Trials, 2016 Oct; 13(5):519-26. [PDF]
Shepherd B, Shaw PA and Dodd L. Using audit Information to adjust parameter estimates for data errors in clinical trials. Clinical Trials, 2012 Dec; 9(6): 721-729. [PDF]
Tebas P, Jadlowsky JK, Shaw PA, Tian L, Esparza E, Brennan A, Kim S, Naing SY, Richardson MW, Vogel AN, Maldini C, Kong H, Liu X, Lacey SF, Bauer AB, Mampe F, Richman LP, Lee G, Ando D, Levine BL, Porter DL, Zhao Y, Siegel DL, Bar KJ, June CH, and Riley JL. CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication. To appear in The Journal of Clinical Investigation.
Diorio C*, Shaw PA*, Orlenka A, Pequignot E, Chen F, Aplenc R, Barrett DM, Bassiri H, Berg RA, Behrens E, Burukpadee C, Callahan C, Finkelstein J, Fitzgerald JC, Frey N, Gonzalez VE, Levine BL, Maude SL, Meyer NJ, Nazimuddin F, Rheingold SR, Rose-John S, White JC, Wertheim G, Zheng Z, June CH, Grupp SA, Melenhorst JJ, Lacey SF, Weiss SL, Teachey DT. Diagnostic Biomarkers to Differentiate Sepsis from Cytokine Release Syndrome in Critically Ill Children. Blood Advances 2020; 4(20): 5174–5183. *Equally contributed. [PDF]
Frey NV, Shaw PA, Hexner EO, Pequignot E, Gill S, Luger SM, Mangan JK, Gilmore J, Loren AW, Perl AE, Maude SL, Grupp SA, Shah NN, Lacey SF, Melenhorst JJ, Levine BL, June CH, Porter DL. Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 2020 Feb 10;38(5):415-422. [PDF]
Gofshteyn J, Shaw PA, Teachey D, Grupp S, Maude S, Banwell B, Chen F, Lacey SF, Melenhorst JJ, Edmonson MJ, Panzer J, Barrett DM and McGuire, J. Neurotoxicity after CTL019 in a Pediatric and Young Adult Cohort. Annals of Neurology, 2018; 84(4): 537-546. [PDF]
Fitzgerald JC, Weiss SL, Maude SL, Barrett DM, Lacey S, Melenhorst J, Shaw PA, Berg RA, June CH, Porter D, Frey NV, Grupp SA, Teachey DT. Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. Critical Care Medicine, 2017 Feb; 45(2), e124–e131. [PDF]
Teachey DT*, Lacey S*, Shaw PA*, Melenhorst J*, Frey N, Barrett D, Chen F, Fitzgerald J, Gonzalez V, Maude S, Pequignot E, Weiss S, June C, Porter D, and Grupp S: Characterization of Cytokine Release Syndrome associated with CT019L therapy for Acute Lymphoblastic Leukemia. Cancer Discovery, 2016 Jun; 6(6):664-79. *co-first authors. [PDF]
Porter DL, Lacey S Grupp S, Hwang W-T, Shaw PA, Frey N, Melenhorst J, Chew A, Gonzalez V, Kalos M, Marcucci K, Maude S, Teachey D, Litchman M, Shen A, Wood P, Levine BL, June CH. Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory CLL. Science Translational Medicine, 2015 Sep; 7(303): 303ra139. [PDF]
Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA. Chimeric antigen receptor T cells for sustained remissions in leukemia. New England Journal of Medicine, 2014; 371: 1507-17. [PDF]
Tebas P, Jadlowsky JK, Shaw PA, Tian L, Esparza E, Brennan A, Kim S, Naing SY, Richardson MW, Vogel AN, Maldini C, Kong H, Liu X, Lacey SF, Bauer AB, Mampe F, Richman LP, Lee G, Ando D, Levine BL, Porter DL, Zhao Y, Siegel DL, Bar KJ, June CH, and Riley JL. CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication. To appear in The Journal of Clinical Investigation.
Wasserman D. Alameh MG, de Silva T, Collini P, Hornsby H, Brown R, LaBranche CC, Edwards RJ, Sutherland L, Santra S, Mansouri K, Gobeil S, McDanal C, Pardi N, Hengartner N, Lin PJC, Tam Y, Shaw PA Lewis MG, Boesler C, Şahin U, Acharya P, Haynes BF, Korber B, Montefiori DC. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. Cell Host & Microbe; 2021 Jan 13; v29: 23–31. [PDF]
Bien-Gund CH, Choi GH, Mashas A, Shaw PA, Miller M, Gross R, and Brady KA. Persistent disparities in smoking rates among PLWH compared to the general population in Philadelphia, 2009-2014 AIDS and Behavior, 2020 Jun 26; v25: 148-153. [PDF]
Steytler J, Shaw PA, Pau AK, Khabo P, Joshi G, Oelofse P, and Phidisa 2 Study Team. Analysis of Site Heterogeneity and HIV Outcomes Across Rural and Urban Study Sites in Phidisa II – A Multi-site Randomized Controlled Antiretroviral Treatment Trial in a South African Military Cohort. Current HIV Research 2017 May;15(3):178-187.
Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D’souza J, Halegoua-De Marzio D, Goldberg DS, Trooskin S, Levine LD, Srinivas SK, Lewis JD, Forde KA, Lo Re V 3rd: Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study. Liver International 38(5): 813-20, May 2018. [PDF]
Gowda C, Coppock D, Brickman C, Shaw PA, Gross R.: Determinants of HIV Transmission Risk Among HIV-Infected Persons Engaged in Care. AIDS Education and Prevention, 2016 Oct; 28(5):440-452.
Gowda C, Brown T, Compher C, Forde K, Kostman J, Shaw PA, Tien P, Lo Re V: Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS, 2016 Oct 23; 30(16):2519-2528.
Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM Prevots DR.: Mortality among Patients with Pulmonary Nontuberculous Mycobacterial Disease. International Journal of TB and Lung Disease, 2016 May; 20(5): 582-587.
Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT, Taubenberger JK. : Evaluation of Anti-Hemagglutinin and Anti-Neuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model. mBio April 2016; 7(2) doi: 10.1128/mBio.00417-16. [PDF]
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702. [PDF]
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702.
Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Seigelman JR, Shallom S, Park IK, Sampaio EP Zelazny AM, Holland SM, Prevots DR. Inhaled amikacin for treatment refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014 Jan; 11(1):30-5.
Marques A, Telford SR, Turk S, Chung E, Williams C, Dardick K, Krause P, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study. Clinical Infectious Diseases, 2014: 58(7), 937-945. [PDF]
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Heon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee DH, Kim CT, Dartois V, Park SK, Cho SN, Barry CE. Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 2012 Oct 18; 367(16):1508-1518. [PDF]
Greenberg DE, Shoffner AR, Marshall-Batty KR, Arora K, Zhao M, Martin R, Ding L, Hammer CH, Shaw PA, Kuhns DB, Malech HL, Gallin JI, Zaramber KA, Holland SM. Serologic Reactivity to the Emerging Pathogen Granulibacter bethesdensis. Journal of Infectious Diseases. 2012 Sep 15;206(6):943-51.
Carroll MW, Lee M, Cai Y, Hallahan CW, Shaw PA, Min JH, Goldfeder LC, Alekseyev V, Grinkrug S, Kang HS, Hwang S, Park HM, Kang E, Lee SY, Jin B, Park HE, Min S, Park SK, Jeon DS, Via LE, Barry CE 3rd. Frequency of Adverse Reactions to First- and Second-line Anti-tuberculosis Chemotherapy in a Korean cohort. The International Journal of Tuberculosis and Lung Disease, 2012 Jul;16(7):961-6.
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE. Innate immunity against Granulibacter bethesdensis, an emerging Gram-negative bacterial pathogen, Infection and Immunity, 2012 Mar; 80 (3) 975-981.
Prevots DR, Shaw PA Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seltz AE, Holland SM Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory Critical Care Medicine 2010 Oct 1; 182 (7): 970-6. [PDF]
Shaw PA Combination versus monotherapy for septic shock patients [Commentary]. Critical Care Medicine. 2010 Sep; 38 (9): 1905-6.
Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Metcalf JA, Masur H, Hassim S. Tuberculosis risk factors and mortality for HIV infected persons receiving antiretroviral therapy in South Africa. AIDS, 2010 Jul 31; 24 (12): 1849-55. [PDF]
Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, and Geller BL. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. Journal of Infectious Diseases, 2010 Jun; 201 (12): 1822-30.
Hassim S, Shaw PA, Sangweni P, Malan L, Ntshani E, Mathibedi MJ, Stubbs N, Metcalf JA, Eckes R, Masur H, Komati S. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clinical Infectious Diseases, 2010 Apr 1; 50(7): 1053-9. [PDF]
Marques A, Shaw P, Schmid CH, Steere A, Kaplan RF, Hassett A, Shapiro E, Wormser GP. Re: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Prolonged Lyme disease treatment: enough is enough [Commentary]. Neurology, 2009 Jan 27;72 (4):383-4.